agilon health, inc.

AGLUnited States

46 filed reports · 486 financial concepts · 12 earnings calls

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$5.93B

FY2025 · to Dec 31, 2025

down −2.1% vs $6.06B

10-K

Net income

-$391M

FY2025 · to Dec 31, 2025

a year earlier: -$260M

10-K

Operating income

-$463M

FY2025 · to Dec 31, 2025

a year earlier: -$292M

10-K

Latest quarter

Revenue

$1.52B

Q3 FY2026 · to Sep 30, 2026

up +5.9% vs $1.44B

10-Q

Net income

$34.9M

Q3 FY2026 · to Sep 30, 2026

a year earlier: -$110M

10-Q

Operating income

$24.1M

Q3 FY2026 · to Sep 30, 2026

a year earlier: -$131M

10-Q

Filed reports

46 reports · Mar 2021 to Sep 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 1 operating metrics, 76 guidance figures, 77 earnings-release figures, 24 commentary passages.

Report typeReportsFactsPeriods
Current · 8-KSEC EDGAR23160Mar 2021 to Sep 2026
Quarterly · 10-QSEC EDGAR172,795Jun 2021 to Sep 2026
Annual · 10-KSEC EDGAR52,754Dec 2021 to Dec 2025
Annual · 10-K/ASEC EDGAR11Dec 2022

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q310-Q2026-09-302026-11-04292Open
FY2026 Q38-K2026-09-302026-11-0479Open
FY2026 Q210-Q2026-06-302026-08-05194Open
FY2026 Q28-K2026-06-302026-08-054Open
FY2026 Q18-K2026-03-312026-05-064Open
FY2026 Q110-Q2026-03-312026-05-06182Open
FY2025 Q48-K2025-12-312026-02-255Open
FY202510-K2025-12-312026-02-25826Open
FY2025 Q38-K2025-09-302025-11-044Open
FY2025 Q310-Q2025-09-302025-11-04155Open
FY2025 Q210-Q2025-06-302025-08-04145Open
FY2025 Q110-Q2025-03-312025-05-06148Open

Financial data

486 concepts · 5,710 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial439 concepts · 5,150 facts · Dec 2019 to Sep 2026

  • 202734 · Jun 2023 to Sep 2026
  • Adjustments to additional paid in capital sharebased compensation requisite service period recognition value34 · Dec 2019 to Sep 2026
  • Depreciation and amortization34 · Dec 2019 to Sep 2026
  • General and administrative expense (US GAAP)34 · Dec 2019 to Sep 2026
  • Income loss from continuing operations before income taxes extraordinary items noncontrolling interest34 · Dec 2019 to Sep 2026
  • Income loss from continuing operations including portion attributable to noncontrolling interest34 · Dec 2019 to Sep 2026
  • Income tax expense benefit34 · Dec 2019 to Sep 2026
  • Net income loss34 · Dec 2019 to Sep 2026
  • Nonoperating income expense34 · Dec 2019 to Sep 2026
  • Operating income loss34 · Dec 2019 to Sep 2026
  • Profit loss34 · Dec 2019 to Sep 2026
  • Revenue34 · Dec 2019 to Sep 2026
  • Stockholders equity including portion attributable to noncontrolling interest34 · Dec 2019 to Sep 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents33 · Dec 2019 to Sep 2026
  • Stock issued during period value stock options exercised33 · Mar 2020 to Sep 2026
  • Depreciation depletion and amortization32 · Dec 2019 to Sep 2026
  • Income loss from equity method investments32 · Dec 2019 to Sep 2026
  • Interest paid net32 · Dec 2019 to Sep 2026
  • Net cash provided by used in financing activities32 · Dec 2019 to Sep 2026
  • Net cash provided by used in investing activities32 · Dec 2019 to Sep 2026
  • Net cash provided by used in operating activities32 · Dec 2019 to Sep 2026
  • Other noncash income expense32 · Dec 2019 to Sep 2026
  • Payments to acquire intangible assets32 · Dec 2019 to Sep 2026
  • Payments to acquire property plant and equipment32 · Dec 2019 to Sep 2026

Product11 concepts · 331 facts · Dec 2019 to Sep 2026

  • Revenue83 · Dec 2019 to Sep 2026
  • Cost of goods and service excluding depreciation depletion and amortization61 · Dec 2021 to Sep 2026
  • Medical Services Expense57 · Dec 2019 to Dec 2022
  • Disposal group including discontinued operation revenue36 · Dec 2019 to Dec 2022
  • Disposal group including discontinued operation costs of goods sold16 · Mar 2020 to Jun 2021
  • Liability for unpaid claims and claims adjustment expense claims paid current year113 · Dec 2019 to Mar 2023
  • Liability for unpaid claims and claims adjustment expense claims paid prior years113 · Dec 2019 to Mar 2023
  • Liability for unpaid claims and claims adjustment expense incurred claims113 · Dec 2019 to Mar 2023
  • Payments for losses and loss adjustment expense13 · Dec 2019 to Mar 2023
  • Supplemental information for property casualty insurance underwriters current year claims and claims adjustment expense13 · Dec 2019 to Mar 2023
  • Supplemental information for property casualty insurance underwriters prior year claims and claims adjustment expense13 · Dec 2019 to Mar 2023

KPI32 concepts · 121 facts · Jun 2021 to Sep 2026

  • Medicare Advantage Membership YoY Change23 · Jun 2021 to Jun 2026
  • Medicare Advantage Membership21 · Jun 2021 to Sep 2026
  • Depreciation and amortization4 · Sep 2025 to Sep 2026
  • Geography Entry Costs4 · Sep 2025 to Sep 2026
  • Medical services expense4 · Sep 2025 to Sep 2026
  • Medical services revenue4 · Sep 2025 to Sep 2026
  • Net income (loss)4 · Sep 2025 to Sep 2026
  • Other(2)4 · Sep 2025 to Sep 2026
  • Other(3)4 · Sep 2025 to Sep 2026
  • Other medical expenses4 · Sep 2025 to Sep 2026
  • Other operating revenue4 · Sep 2025 to Sep 2026
  • Severance and related costs4 · Sep 2025 to Sep 2026
  • Stock-based compensation expense4 · Sep 2025 to Sep 2026
  • ACO Model Members1,22 · Sep 2025 to Sep 2026
  • Adjustments on sale of assets, net2 · Sep 2025 to Sep 2026
  • Avg. Medicare Advantage Members2 · Sep 2025 to Sep 2026
  • Changes in operating assets and liabilities2 · Sep 2025 to Sep 2026
  • Loss (income) from equity method investments2 · Sep 2025 to Sep 2026
  • Net cash provided by (used in) financing activities2 · Sep 2025 to Sep 2026
  • Net cash provided by (used in) investing activities2 · Sep 2025 to Sep 2026
  • Net cash provided by (used in) operating activities2 · Sep 2025 to Sep 2026
  • Other assets2 · Dec 2025 to Sep 2026
  • Other, net2 · Sep 2025 to Sep 2026
  • Proceeds from (payments for) equity issuances, net2 · Sep 2025 to Sep 2026

Guidance2 concepts · 78 facts · May 2021 to Nov 2026

  • Revenue Guidance76 · May 2021 to Nov 2026
  • Gross Margin Guidance2 · Nov 2025

Segment2 concepts · 30 facts · Dec 2022 to Sep 2026

  • General and administrative expense (US GAAP)15 · Dec 2022 to Sep 2026
  • Segment reporting other item amount15 · Dec 2022 to Sep 2026

Segments

361 facts

Figures broken down by business line, region, product or another axis the company reports on.

Product or service18 members · 331 facts

  • Medical Claims And Related Payables78 · Dec 2019 to Mar 2023
  • Medical Services Revenue40 · Dec 2019 to Mar 2024
  • Medical Services38 · Dec 2022 to Sep 2026
  • Other Operating37 · Dec 2022 to Sep 2026
  • Other Operating Revenue33 · Dec 2019 to Mar 2024
  • Depreciation And Amortization112 · Dec 2019 to Dec 2022
  • Medical Services Expense112 · Dec 2019 to Dec 2022
  • Medical Services Revenue112 · Dec 2019 to Dec 2022
  • Other Medical Expenses112 · Dec 2019 to Dec 2022
  • Other Operating Revenue112 · Dec 2019 to Dec 2022
  • General And Administrative110 · Dec 2019 to Sep 2022
  • Depreciation And Amortization6 · Mar 2020 to Sep 2021
  • General And Administrative6 · Mar 2020 to Sep 2021
  • Medical Services Expense6 · Mar 2020 to Sep 2021
  • Other Medical Expenses6 · Mar 2020 to Sep 2021
  • Product And Service Other6 · Dec 2021 to Dec 2023
  • Impairments Recoveries13 · Dec 2019 to Dec 2021
  • Other Medical2 · Sep 2025 to Sep 2026

Statement business segments1 member · 30 facts

  • Reportable30 · Dec 2022 to Sep 2026

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary7 claims from 1 report · Sep 2026
  • Management discussion (MD&A) commentary17 claims from 1 report · Sep 2026
  • Risk-factor changes34 claims from 3 reports · Dec 2022 to Dec 2024
  • Risk factors231 risks from 4 annual reports · 2021 to 2024

Earnings calls

12 calls · Feb 2024 to Nov 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q32026-11-04
  • FY2026 Q22026-08-05
  • FY2026 Q12026-05-06
  • FY2025 Q42026-02-26
  • FY2025 Q32025-11-04
  • FY2025 Q22025-08-06
  • FY2025 Q12025-05-06
  • FY2024 Q42025-02-26
  • FY2024 Q32024-11-10
  • FY2024 Q22024-08-15
  • FY2024 Q12024-05-08
  • FY2023 Q42024-02-27

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of agilon health, inc. (AGL) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.